youtube_live
Q1 2026 tulu • 4 päeva pärast
Kuva üksikasjadchevron_right
BNTX:NASDAQ
BioNTech SE - ADR
103,45 $
0,00%
(0,00) 1 p
98,50 $
arrow_downward
−4,78% (−4,95)todayEnne avanemist
Suletud: 30. apr, 16:00:01 GMT −4 · USD
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse BNTX põhistatistika genereerimine…
Turu kapit.
26,16 mld
Keskm. maht
1,54 mln
Maht
8,20 tuh
52 näd kõrgeim
123,98 $
52 näd madalaim
79,52 $
Aktsiatulu
−5,51 $
Beeta
1,56
Käibivad aktsiad
252,88 mln
Töötajate arv
8 tuh
Uudised
Erinevatest veebiallikatest
TipRanks
·
15 tunni eest
Why BioNTech Stock Is Suddenly Sinking Today
Stock Traders Daily
·
1 päeva eest
Avoiding Lag: Real-Time Signals in (BNTX) Movement
Profiil
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
Teave üksuse BioNTech SE - ADR kohta
AI genereeritud sisu võib sisaldada vigu. Lisateave